The study focuses on the 25 most relevant pharmaceutical companies in Spain , evaluating aspects such as SEO optimization, the relevance of keywords, the positioning of associated products, and the quality of web content. According to José Luis Agudo, head of SEO at ROI UP Group, despite the improvements, there is still a long way to go to effectively optimize the digital presence of these companies. The challenges range from poorly executed migrations to technical deficiencies and the need for better optimized content.
One notable aspect of the study is the leadership of Spanish companies in terms of organic traffic, demonstrating the importance and potential of the national market. However, the loss of organic traffic in 17 of the 25 companies analysed shows the urgent need to adapt to Google updates in order not to be left behind.
Improvements and opportunities on the horizon
Roche has seen a significant improvement in its SEO ranking, united states of america number data climbing 16 points and placing itself in a prime position. This progress is a reflection of the opportunities that exist for those companies that commit to a robust SEO strategy focused on content quality and user experience.
In addition, the observatory includes data from the Google Lighthouse audit, showing an improvement in the average score for mobile and desktop devices, indicating a positive trend towards web optimization and improved user experience.
In conclusion, the II Pharma SEO 2024 Observatory shows that, although the Spanish pharmaceutical sector is making progress in terms of SEO and digital presence, there are still significant areas for improvement. The key is in the quality of the content and in offering a user experience that meets the EEAT criteria (Experience, Expertise, Authority and Trustworthiness). This will not only improve search engine positioning, but will also reinforce the authority and trust of brands in the competitive digital market.